Attached files
file | filename |
---|---|
10-Q/A - BODISEN BIOTECH, INC | v211793_10qa.htm |
EX-31.1 - BODISEN BIOTECH, INC | v211793_ex31-1.htm |
EX-31.2 - BODISEN BIOTECH, INC | v211793_ex31-2.htm |
EX-32.1 - BODISEN BIOTECH, INC | v211793_ex32-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Bodisen Biotech, Inc. (the “Company”) on
Form 10-Q/A for the period ended September 30, 2010, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Junyan
Tong, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
section 1350 of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.
Date:
February 16, 2011
/s/ Junyan
Tong
|
|
Junyan
Tong
|
|
Chief
Financial Officer
|
|
(principal
financial and accounting
officer)
|